Patient safety
Patient safety is important to us. Reporting adverse reactions, incidents and other safety concerns contributes to the continuous monitoring of our products and helps identify new information related to their use.
The role of pharmacovigilance
Pharmacovigilance contributes to monitoring the safety of medicinal products by identifying and preventing adverse reactions or other risks associated with their use.
You can always report
If you or someone close to you has experienced a suspected reaction after using a medicinal product, an undesirable effect associated with a food supplement, or an incident involving a medical device, you can submit a report even if you are not certain that the product was the cause.
Report an adverse reaction or incident
This form is intended for reporting adverse reactions and incidents and does not replace medical advice. If your condition worsens, seek medical attention immediately. In a medical emergency, call 112.
What happens after you report? Our team will review the information and may contact you for clarification. Relevant data will be shared with the marketing authorisation holder or manufacturer and the competent authority, as applicable.
Other ways to report
Pharmacovigilance contact
- Emailpharmacovigilance@toppharm.md
- 24/7 phone+373 78 897 141
- Office phone+373 22 241 126
Reporting to AMDM
You may also report directly to the Medicines and Medical Devices Agency (AMDM).
- AMDM emailfarmacovigilenta@amdm.gov.md
- AMDM phone+373 22 88 43 38
Pharmacovigilance and medical device vigilance
We provide local pharmacovigilance and medical device vigilance services for our partners in the Republic of Moldova, including the collection and assessment of safety information and communication with the competent authority.
Our system operates in compliance with Good Pharmacovigilance Practices (GVP) and applicable national and European requirements.
Our services include
- Local Qualified Person for Pharmacovigilance with 24/7 availability
- Management of adverse reaction reports and other safety information
- Local literature and regulatory intelligence
- Submissions and communication with local regulatory authorities
- Support for PSURs, RMPs and risk minimisation measures
- Preparation and support for pharmacovigilance audits and inspections